Carson Wealth (CWM LLC)
RIGL icon

Carson Wealth (CWM LLC)’s Rigel Pharmaceuticals RIGL Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.5K Sell
832
-959
-54% -$32.2K ﹤0.01% 4333
2025
Q4 		$77K Buy
1,791
+1,226
+217% +$46.2K ﹤0.01% 3276
2025
Q3 		$16K Sell
565
-61
-10% -$1.82K ﹤0.01% 4249
2025
Q2 		$12K Buy
626
+301
+93% +$5.71K ﹤0.01% 4214
2025
Q1 		$6K Buy
325
+236
+265% +$4.79K ﹤0.01% 4401
2024
Q4 		$1K Sell
89
-1
-1% -$19 ﹤0.01% 4784
2024
Q3 		$1K Buy
90
+47
+109% +$553 ﹤0.01% 4689
2024
Q2 		$0 Buy
+43
New +$450 ﹤0.01% 4885
2023
Q3 		– Sell
-9
Closed – – 4487
2023
Q2 		$0 Hold
9
– – ﹤0.01% 4425
2023
Q1 		$0 Buy
+9
New +$143 ﹤0.01% 4304
2022
Q2 		– Sell
-7
Closed – – 4054
2022
Q1 		$0 Buy
+7
New +$190 ﹤0.01% 3817

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Carson Wealth (CWM LLC)'s RIGL Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Rigel Pharmaceuticals (RIGL) stake by 54% in Q1 2026, selling an estimated $32.2K and leaving 832 shares worth $22.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4333.

Carson Wealth (CWM LLC) first reported a position in RIGL in Q1 2022 and has held it in 11 quarters since. The position peaked at $77K in Q4 2025. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.

  • Carson Wealth (CWM LLC) held 832 shares of Rigel Pharmaceuticals worth $22.5K as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 959 Rigel Pharmaceuticals shares in Q1 2026, an estimated $32.2K.
  • Rigel Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4333 holding.
  • Carson Wealth (CWM LLC) first reported a position in Rigel Pharmaceuticals in Q1 2022 and has held it in 11 quarters since.
  • Carson Wealth (CWM LLC)'s Rigel Pharmaceuticals position peaked at $77K in Q4 2025.
  • 159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.